In vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy.

Dose verification in carcinoma of uterine cervix patients undergoing 3D conformal radiotherapy with Farmer type ion chamber. J Med Phys (2014) 0.84

In regard to Marcié et al.: in vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy (Int J Radiat Oncol Biol Phys 2005;61:1603-1606). Int J Radiat Oncol Biol Phys (2005) 0.75

Characteristics of mobile MOSFET dosimetry system for megavoltage photon beams. J Med Phys (2014) 0.75

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol (2012) 2.62

Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol (2008) 2.03

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer (2011) 1.78

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res (2003) 1.64

NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett (2006) 1.49

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.43

Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev (2003) 1.33

Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. Radiother Oncol (2012) 1.10

Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer (2013) 1.10

Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2. Eur J Cancer (2012) 1.10

Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol (2012) 1.08

Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival. Cancer (2008) 1.03

[Standards, options and recommendations for nutritional support in bone marrow transplant patients]. Bull Cancer (2002) 1.01

Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol (2005) 1.00

Free-flap head and neck reconstruction and quality of life: a 2-year prospective study. Laryngoscope (2008) 0.99

Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing. Int J Cancer (2002) 0.97

Prognostic value of P53 mutations in rectal carcinoma. Int J Cancer (2002) 0.96

Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility. Carcinogenesis (2004) 0.93

Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan? Cancer (2004) 0.92

The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis (2006) 0.92

Radiotherapy for elderly patients with breast cancer. J Clin Oncol (2013) 0.90

Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture. Clin Cancer Res (2012) 0.86

Radical ablative surgery and radial forearm free flap (RFFF) reconstruction for patients with oral or oropharyngeal cancer: postoperative outcomes and oncologic and functional results. Acta Otolaryngol (2009) 0.85

Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy. Gynecol Oncol (2006) 0.85

Creatine but not betaine supplementation increases muscle phosphorylcreatine content and strength performance. Amino Acids (2011) 0.84

Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg (2009) 0.83

[Preneoplastic anal lesions and anal canal carcinoma]. Bull Cancer (2003) 0.83

Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study. Radiother Oncol (2006) 0.83

Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02). Clin Cancer Res (2012) 0.81

Creatine supplementation spares muscle glycogen during high intensity intermittent exercise in rats. J Int Soc Sports Nutr (2010) 0.81

Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement. Radiother Oncol (2008) 0.80

Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck. Support Care Cancer (2011) 0.80

Miconazole mucoadhesive tablet for oropharyngeal candidiasis. Expert Rev Anti Infect Ther (2011) 0.79

Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy. Dis Colon Rectum (2013) 0.79

Efficacy of low-level laser therapy (LLLT) in oral mucositis: what have we learned from randomized studies and meta-analyses? Photomed Laser Surg (2012) 0.79

Oral cavity squamous cell carcinoma in 260 patients aged 80years or more. Radiother Oncol (2009) 0.79

A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer (2015) 0.78

[The cost of intensity modulated radiation therapy in head and neck cancers: results of the 2002 STIC study]. Bull Cancer (2006) 0.77

High-resolution analysis of DNA copy number alterations in rectal cancer: correlation with metastasis, survival, and mRNA expression. Strahlenther Onkol (2014) 0.76

Prediction of response in rectal cancer: we are still far from the "crystal ball". Dig Liver Dis (2010) 0.76

Reply to R. Glynne-Jones et al. J Clin Oncol (2013) 0.75

Gastric adenocarcinoma treated with R0-R1 surgical resection and intraoperative radiotherapy (IORT) plus external beam radiation therapy (EBRT). Suppl Tumori (2003) 0.75

[Peri-operative treatments for rectal cancer]. Rev Prat (2015) 0.75

[Chemoradiotherapy and anal canal cancer]. Bull Cancer (2005) 0.75

[Rectal cancer Information dedicated to cancer patients and relatives]. Bull Cancer (2006) 0.75

A networking for patient recruitment: the experience of choroidal melanoma. Radiother Oncol (2004) 0.75

[Radiation-induced mucositis of the aerodigestive tract: prevention and treatment. MASCC/ISOO mucositis group's recommendations]. Bull Cancer (2006) 0.75

[Cutaneous adverse reactions of EGFR (epidermal growth factor receptor)-inhibitors: therapeutic algorithm of the French PROCUR group]. Bull Cancer (2013) 0.75

[Occupational hazard related to ionizing radiation and surveillance of exposed people]. Rev Prat (2015) 0.75

[Upper aerodigestive tract carcinoma: therapeutic management]. Presse Med (2007) 0.75

[Oxaliplatin and preoperative chemoradiotherapy in rectal cancer]. Bull Cancer (2006) 0.75

[Advances in radiation oncology for metastatic bone disease]. Bull Cancer (2013) 0.75

[Osteonecrosis of the jaw and bisphophonates in oncology]. Bull Cancer (2008) 0.75